Down-regulation of IgG4 in nasopharyngeal environment suggested mocusal immune abnormalities upon SARS-CoV-2 viral infection at the point of entry and decreased coagulation factor 5 and fibronectin suggested an increased chance of thrombotic events in COVID-19 patients. This evidence concerns the gene FN1 and COVID-19.